Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Erlichman C, Adjei AA, Alberts SR, Sloan JA, Goldberg RM, Pitot HC, Rubin J, Atherton PJ, Klee GG, Humphrey R.
Erlichman C, et al. Among authors: pitot hc.
Ann Oncol. 2001 Mar;12(3):389-95. doi: 10.1023/a:1011183905848.
Ann Oncol. 2001.
PMID: 11332153
Free article.
Clinical Trial.